美国医疗保健 3PL（第三方物流）市场规模、份额和趋势分析报告：2023-2030 年按行业、供应链、服务类型、地区、细分市场划分的趋势

美国医疗保健 3PL（第三方物流）市场增长和趋势

GrandView Research, Inc. 的最新报告显示，到 2030 年，美国医疗保健 3PL（第三方物流）市场预计将达到 1,608 亿美元。

由于美国在药品和生物製品市场的主导地位、大量参与者的存在以及生物製药进出口的增加，预计该市场在预测期内的复合年增长率为 9.04%。

COVID-19 大流行期间，该国对 COVID-19 疫苗的高需求促使医院、公共机构和其他机构与第三方物流服务提供商合作。 例如，2020 年，俄亥俄州卫生部与 Cardinal Health 合作分发了 COVID-19 疫苗。 预计这将改善疫情期间该国对第三方物流服务的需求。

在日本，用于治疗癌症、自身免疫性疾病、神经系统疾病等的生物製药的需求正在增加。 此外，日本正在进行大量的药物研究。 所有这些因素预计将在预测期内增加对第三方物流服务的需求。

过去五年，大量药品、生物製药和医疗器械在该国获得批准和上市。 例如，2023年1月，Amgen Pipeline推出了Amgevita生物仿製药，用于治疗活动性多关节型幼年特发性关节炎。 同样，2022 年 12 月，美国 FDA 批准 Briambi 的 ublituximab-xiiy 用于治疗多发性硬化症。 预测期内类似药物在美国的批准和上市预计将为美国的第三方物流服务创造机会。

此外，市场主要参与者的战略举措预计将为未来几年的区域市场提供增长机会。 例如，2023 年 1 月，Censinet 获得 900 万美元资金，用于加速医疗保健领域的第三方风险管理。 本轮融资由 MemorialCare Innovation Fund 领投，其中包括 Ballad Ventures 和 Rex Health Ventures，使该公司的融资总额超过 2200 万美元。

美国医疗保健 3PL（第三方物流）市场亮点

• 按行业划分，生物製药领域占据市场主导地位，2022 年份额超过 61.00%。 该领域的增长是由技术进步和推出的生物仿製药数量增加推动的。
• 另一方面，冷链物流行业预计将在未来几年占据较大的市场份额。 这是由于美国对温度敏感的药品、生物製品、疫苗和其他医疗保健产品的需求增加。
• 按服务类型划分，仓储领域到 2022 年将占 43.29% 的份额，能够提供温控存储、符合监管标准并提供库存管理解决方案。因为
• 由于医疗保健基础设施健全、药品製造商集中以及交通基础设施健全等因素，2022 年中西部地区在美国医疗保健 3PL（第三方物流）行业中占据主导地位。

内容

第一章调查方法及范围

• 信息获取
• 信息或数据分析
• 市场范围和细分定义
• 市场模式

第 2 章执行摘要

• 市场概况
• 片段快照
• 竞争格局快照

第三章市场变量、趋势和范围

• 市场细分和范围
• 市场体系展望
  • 母公司市场前景
  • 相关/补充市场前景
• 市场趋势和展望
• 市场驱动因素分析
• 市场製约因素分析
• 商业环境分析
  • SWOT 分析；按因素（政治/法律、经济/技术）
  • 波特五力分析
• COVID-19 感染的影响分析

第四章行业分析

• 美国医疗保健3PL（第三方物流）市场：行业波动分析
• 生物製药
• 药品
• 医疗设备

第五章供应链业务分析

• 美国医疗保健 3PL（第三方物流）市场：供应链波动分析
• 冷链
• 非冷链

第六章服务类型业务分析

• 美国医疗保健 3PL（第三方物流）市场：服务类型变化分析
• 交通
• 仓库储存
• 其他

第七章区域分析

• 美国医疗保健 3PL（第三方物流）市场：区域变化分析
• 东北
• 西南航空
• 西方
• 东南
• 中西部

第 8 章竞争格局

• 公司分类
• 2022 年公司市场分析
• 战略规划
• 参与公司概览
  • ShipMonk
  • DHL International
  • Cardinal Health
  • MCKESSON CORPORATION
  • Kuehne+Nagel
  • AmerisourceBergen Corporation
  • CH Robinson
  • CEVA Logistics
  • Promptus, LLC
  • FedEx

U.S. Healthcare Third-party Logistics Market Growth & Trends

The U.S. healthcare third-party logistics market size is expected to reach USD 160.80 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 9.04% over the forecast period owing to the dominance of the U.S. in the pharmaceutical and biologics drugs market, the presence of a large number of players, and the rise in imports and exports of biopharmaceuticals.

High demand for COVID-19 vaccines in the country during the COVID-19 pandemic contributed to the hospitals, public organizations, and other institutions entering into partnerships with third-party logistics service providers. For instance, in 2020, the Ohio Department of Health partnered with Cardinal Health for the distribution of the COVID-19 vaccine. This is expected to have improved the demand for third-party logistics services in the country during the pandemic period.

There is a growing demand for biopharmaceuticals in the country for treating diseases such as cancer, autoimmune diseases, neurological diseases, and others. Furthermore, a significant number of researches are conducted in the country on drugs. All these factors are expected to boost the demand for third-party logistics services over the forecast period.

During the last five years, a significant number of pharmaceutical, biopharmaceutical, and medical devices were approved and launched in the country. For instance, in January 2023, Amgen launched Amjevita biosimilar for treating active polyarticular juvenile idiopathic arthritis. Similarly, in December 2022, the USFDA approved a drug named ublituximab-xiiy from Briumvi for treating multiple sclerosis. Similar drug approvals and drug launches in the country in the forecast period are expected to create opportunities for third-party logistics services in the U.S.

Furthermore, strategic initiatives undertaken by key entities in the market is expected to create growth opportunity for the regional market in the coming years. For instance, in January 2023, Censinet received funding of USD 9 million to accelerate third-party risk management in healthcare. This funding was led by the MemorialCare Innovation Fund including Ballad Ventures and Rex Health Ventures, bringing the Company's total funding to over USD 22 million.

U.S. Healthcare Third-party Logistics Market Highlights

• Based on industry, the biopharmaceutical segment dominated the market with a share of over 61.00% in 2022. The growth of the segment is attributed owing to technological advancements, and an increase in the number of biosimilar launches
• On the other hand, the cold chain logistics segment is expected to occupy a significant market share in the coming years. This is attributed due to the increasing demand for temperature-sensitive pharmaceuticals, biologics, vaccines, and other healthcare products in the U.S.
• Based on service type, the warehousing and storage segment captured the major share of 43.29% in 2022 owing to its capacity to offer temperature-controlled storage, adhere to regulatory standards, and provide inventory management solutions
• Midwest region dominated the U.S. healthcare third-party logistics industry in 2022 due to factors such as robust healthcare infrastructure, the concentration of pharmaceutical manufacturers, and robust transportation infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Driver Analysis
• 3.5. Market Restraint Analysis
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.6.2. Porter's Five Forces Analysis
• 3.7. COVID-19 Impact Analysis

Chapter 4. Industry Analysis

• 4.1. U.S. Healthcare Third-Party Logistics Market: Industry Movement Analysis
• 4.2. Biopharmaceutical
  • 4.2.1. Biopharmaceutical Market, 2018 - 2030 (USD Billion)
• 4.3. Pharmaceutical
  • 4.3.1. Pharmaceutical Market, 2018 - 2030 (USD Billion)
• 4.4. Medical Device
  • 4.4.1. Medical Device Market, 2018 - 2030 (USD Billion)

Chapter 5. Supply Chain Business Analysis

• 5.1. U.S. Healthcare Third-Party Logistics Market: Supply Chain Movement Analysis
• 5.2. Cold chain
  • 5.2.1. Cold chain Market, 2018 - 2030 (USD Billion)
• 5.3. Non-Cold chain
  • 5.3.1. Non-Cold Chain Market, 2018 - 2030 (USD Billion)

Chapter 6. Service Type Business Analysis

• 6.1. U.S. Healthcare Third-Party Logistics Market: Service Type Movement Analysis
• 6.2. Transportation
  • 6.2.1. Transportation Market, 2018 - 2030 (USD Billion)
    • 6.2.1.1. Air Freight
    • 6.2.1.1.1. Air freight Market, 2018 - 2030 (USD Billion)
    • 6.2.1.2. Sea freight
    • 6.2.1.2.1. Sea freight Market, 2018 - 2030 (USD Billion)
    • 6.2.1.3. Overland transportation
    • 6.2.1.3.1. Overland transportation Market, 2018 - 2030 (USD Billion)
• 6.3. Warehousing and storage
  • 6.3.1. Warehousing and storage Market, 2018 - 2030 (USD Billion)
• 6.4. Others
  • 6.4.1. Others Logistic Market, 2018 - 2030 (USD Billion)

Chapter 7. Region Analysis

• 7.1. U.S. Healthcare Third-Party Logistics Market: Region Movement Analysis
• 7.2. Northeast
  • 7.2.1. Northeast Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.3. Southwest
  • 7.3.1. Southwest Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.4. West
  • 7.4.1. West Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.5. Southeast
  • 7.5.1. Southeast Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.6. Midwest
  • 7.6.1. Midwest Healthcare Logistic Market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis, 2022
• 8.3. Strategy Mapping
  • 8.3.1. Expansion
  • 8.3.2. Acquisition
  • 8.3.3. Collaborations
  • 8.3.4. New Product Launches
  • 8.3.5. Partnerships
  • 8.3.6. Others
• 8.4. Participant's overview
  • 8.4.1. ShipMonk
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. DHL International
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Cardinal Health
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. MCKESSON CORPORATION
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Kuehne+Nagel
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. AmerisourceBergen Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. C.H. Robinson
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. CEVA Logistics
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Promptus, LLC
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. FedEx
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global U.S Healthcare Third-party Logistics Market by Industry, 2018 - 2030 (USD Billion)
• Table 4. U.S Healthcare Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
• Table 5. U.S Healthcare Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
• Table 6. U.S Healthcare Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
• Table 7. U.S Healthcare Third-party Logistics Market by End Use, 2018 - 2030 (USD Billion)
• Table 8. U.S Healthcare Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Healthcare Third-party Logistics Market, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 10 Penetration & Growth Prospect Mapping
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
• Fig. 14 Regional Marketplace: Key Takeaways
• Fig. 15 U.S. Healthcare Third-party Logistics Market for Biopharmaceutical, 2018 - 2030 (USD Billion)
• Fig. 16 U.S. Healthcare Third-party Logistics Market for Pharmaceutical, 2018 - 2030 (USD Billion)
• Fig. 17 U.S. Healthcare Third-party Logistics Market for Medical Device, 2018 - 2030 (USD Billion)
• Fig. 18 U.S. Healthcare Third-party Logistics Market for Cold Chain, 2018 - 2030 (USD Billion)
• Fig. 19 U.S. Healthcare Third-party Logistics Market for Non-cold Chain, 2018 - 2030 (USD Billion)
• Fig. 20 U.S. Healthcare Third-party Logistics Market for Transportation, 2018 - 2030 (USD Billion)
• Fig. 21 U.S. Healthcare Third-party Logistics Market for Air Freight, 2018 - 2030 (USD Billion)
• Fig. 22 U.S. Healthcare Third-party Logistics Market for Sea Freight, 2018 - 2030 (USD Billion)
• Fig. 23 U.S. Healthcare Third-party Logistics Market for Overland Transportation, 2018 - 2030 (USD Billion)
• Fig. 24 U.S. Healthcare Third-party Logistics Market for Warehousing and storage, 2018 - 2030 (USD Billion)
• Fig. 25 U.S. Healthcare Third-party Logistics Market for Others, 2018 - 2030 (USD Billion)
• Fig. 26 U.S. Healthcare Third-party Logistics Market for Northeast, 2018 - 2030 (USD Billion)
• Fig. 27 U.S. Healthcare Third-party Logistics Market for Southwest, 2018 - 2030 (USD Billion)
• Fig. 28 U.S. Healthcare Third-party Logistics Market for West, 2018 - 2030 (USD Billion)
• Fig. 29 U.S. Healthcare Third-party Logistics Market for Southeast, 2018 - 2030 (USD Billion)
• Fig. 30 U.S. Healthcare Third-party Logistics Market for Midwest, 2018 - 2030 (USD Billion)